Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 5/12/2026BrightGene Reports Phase 3 Success for Dual GLP-1/GIP Obesity Drug BGM...
  • 5/12/2026China Approves Novel EGFR, JAK2 Therapies as Wave of Innovative INDs A...
  • 5/12/2026DualityBio Reports Strong First-Line TNBC Data for DB-1305/BNT325 Plus...
  • 5/12/2026CytoCares Reports First-in-Human AACR Data for CD19/CD3/CD28 Trispecif...
  • 5/12/2026BeOne Culls Multiple Early Oncology Programs, Halts Phase 2 IRAK4 Degr...
  • 5/12/2026Sinocelltech Advances Dual Trispecific Antibody Combo Into Phase 1b/2 ...
  • 5/8/2026China Poised to Lead Next Wave of CAR-T Innovation in Solid Tumors, Sa...
  • 5/8/2026InnoCare Advances CDH17 ADC Into Clinic as Competition Builds in GI Ca...
  • 5/7/2026Cutia Wins China Approval for CU-30101 Topical Anesthetic Cream
  • 5/7/2026InnoCare Secures China IND Approval for Novel CDH17-Targeted ADC ICP-B...
  • 5/7/2026Sino Biopharm Wins China Approval for World's First CDK2/4/6 Inhibitor...
  • 5/7/2026Amgen Wins China Approval for Evenity (Romosozumab)
  • 5/5/2026China Clears 14 Novel INDs Last Week, Spotlighting Obesity, Oncology a...
  • 5/5/2026Chinese Insulin Wins FDA Approval, Marking Breakthrough Entry Into U.S...
  • 5/5/2026Sinocelltech Advances CD20×CD3 T-Cell Engager Into Phase 3
  • 5/5/2026Bambusa Completes Enrollment in Mid-Stage Trial of Bispecific Antibody...
  • 5/1/2026EU Approves Henlius–Organon Pertuzumab Biosimilar POHERDY
  • 5/1/2026China Approves Two Innovative Homegrown Therapies Ahead of Holiday Bre...
  • 4/30/2026CDE Accepts Bayer Filing for FXIa Inhibitor Asundexian in Secondary St...
  • 4/29/2026Insilico Secures China IND Clearance for AI-Discovered IPF Drug Rentos...
  • 4/28/2026Gritgen Reports Durable Efficacy of Hemophilia A Gene Therapy at WFH 2...
  • 4/28/2026Hengrui Launches Large-Scale Phase 3 Trial of GLP-1/GIP Agonist HRS953...
  • 4/28/2026Seven Novel Drug Candidates Win IND Clearance in China Across Modaliti...
  • 4/28/2026Simcere Withdraws and Plans Rapid Resubmission of Rademikibart NDA in ...
  • 4/28/2026Theia Reports Early Clinical Progress for iPSC-Derived Cell Therapy in...
  • 4/23/2026Transcenta Showcases Preclinical Data for LIV1 ADC TST013 at AACR 2026
  • 4/23/20263D Medicines Presents Early Clinical and Preclinical Data for ¹⁷⁷Lu...
  • 4/22/2026Lepu Showcases Dual Oncology Programs at AACR 2026 with Promising Prec...
  • 4/22/2026Hansoh Pharma Reports Positive Mid-Stage Data for Orexin-2 Antagonist ...
  • 4/22/2026GenFleet Unveils FIC KEAP1–NRF2 Molecular Glue GFH603 at AACR 2026
  • Page:1/22 Total number of articles:657: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group